Evidence map›Paper›PMID 28874543›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2017

Structure of the Ebola virus envelope protein MPER/TM domain and its interaction with the fusion loop explains their fusion activity.

Jinwoo Lee, David A Nyenhuis, Elizabeth A Nelson, David S Cafiso, Judith M White, Lukas K Tamm

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 69 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. A novelMicrobiology spectrum · 2023
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Jinwoo LeeCenter for Membrane and Cell Physiology, University of Virginia, Charlottesville, VA 22908.
David A NyenhuisCenter for Membrane and Cell Physiology, University of Virginia, Charlottesville, VA 22908.
Elizabeth A NelsonCenter for Membrane and Cell Physiology, University of Virginia, Charlottesville, VA 22908.
David S CafisoCenter for Membrane and Cell Physiology, University of Virginia, Charlottesville, VA 22908.
Judith M WhiteCenter for Membrane and Cell Physiology, University of Virginia, Charlottesville, VA 22908.
Lukas K TammCenter for Membrane and Cell Physiology, University of Virginia, Charlottesville, VA 22908; lkt2e@virginia.edu.
University of Virginia · US

Funding

TRAINING IN CELL AND MOLECULAR BIOLOGYT32GM008136 · NIGMS · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI STUKENBERG, P. TODD · 1985 to 2020
$8.5M
VIRAL SPIKE GLYCOPROTEIN-MEDIATED MEMBRANE POTENTIALR01AI030557 · NIAID · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI TAMM, LUKAS K · 1991 to 2022
$6.2M
Training in Molecular BiophysicsT32GM080186 · NIGMS · UNIVERSITY OF VIRGINIA · PI NAKAMOTO, ROBERT K. · 2008 to 2019
$1.5M
Combinations of Approved Drugs to Combat Ebola VirusR01AI114776 · NIAID · UNIVERSITY OF VIRGINIA · PI WHITE, JUDITH M. · 2015 to 2017
$1.5M
STICS: Surface-Tethered Iterative Carbohydrate SynthesisR21GM072693 · NIGMS · UNIVERSITY OF MISSOURI-ST. LOUIS · PI STINE, KEITH J. · 2006 to 2007
$394k
NIAID NIH HHS R01 AI030557NIAID NIH HHS R01 AI114776NIGMS NIH HHS R21 GM072693NIGMS NIH HHS T32 GM008136NIGMS NIH HHS T32 GM080186
6 · The paper itself

Abstract

Ebolavirus (EBOV), an enveloped filamentous RNA virus causing severe hemorrhagic fever, enters cells by macropinocytosis and membrane fusion in a late endosomal compartment. Fusion is mediated by the EBOV envelope glycoprotein GP, which consists of subunits GP1 and GP2. GP1 binds to cellular receptors, including Niemann-Pick C1 (NPC1) protein, and GP2 is responsible for low pH-induced membrane fusion. Proteolytic cleavage and NPC1 binding at endosomal pH lead to conformational rearrangements of GP2 that include exposing the hydrophobic fusion loop (FL) for insertion into the cellular target membrane and forming a six-helix bundle structure. Although major portions of the GP2 structure have been solved in pre- and postfusion states and although current models place the transmembrane (TM) and FL domains of GP2 in close proximity at critical steps of membrane fusion, their structures in membrane environments, and especially interactions between them, have not yet been characterized. Here, we present the structure of the membrane proximal external region (MPER) connected to the TM domain: i.e., the missing parts of the EBOV GP2 structure. The structure, solved by solution NMR and EPR spectroscopy in membrane-mimetic environments, consists of a helix-turn-helix architecture that is independent of pH. Moreover, the MPER region is shown to interact in the membrane interface with the previously determined structure of the EBOV FL through several critical aromatic residues. Mutation of aromatic and neighboring residues in both binding partners decreases fusion and viral entry, highlighting the functional importance of the MPER/TM-FL interaction in EBOV entry and fusion.

Indexed as

Cell MembraneEbolavirusProtein DomainsProtein Structure, SecondaryStructure-Activity RelationshipViral Envelope ProteinsViral Fusion ProteinsVirus Internalizationenvelope glycoprotein, Ebola virusViral Envelope ProteinsViral Fusion ProteinsEbola virusenvelope proteinmembrane fusionmembrane proteinstructure

Identifiers

PMID28874543
PMCPMC5617291
OpenAlexW2753176129

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.